Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R21/R33)

Post Date

August 26th 2010

Application Due Date

September 7th 2013

Funding Opportunity Number

PAS-10-274

CFDA Number(s)

93.279

Funding Instrument Type(s)

Grant

Funding Activity Categories

Education
Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $250000

Grant Description

Purpose. The National Institute on Drug Abuse (NIDA), through the issuance of this program announcement, with set aside funds (PAS), invites Phased Innovation (R21/R33) grant applications from new-to-NIH investigators into basic chemistry research applied to drug abuse and addiction. NIDA invites newly independent investigators and investigators who have not had previous NIH funding to submit applications for research projects related to NIDAs mission. Mechanism of Support. This FOA will utilize the Exploratory/Developmental Phased Innovation (R21/R33) grant mechanism. Applicants will submit a single application organized into two phases, beginning with discussion of the R21 phase followed by discussion of the R33 phase. Applicants using only the R21 mechanism or only the R33 mechanism will not be considered. Funds Available and Anticipated Number of Awards. NIDA intends to commit approximately $1,500,000 in FY 2011 to fund 6 to 8 grants. Funding will be based on scientific and technical merit, program priorities, and availability of funds. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award also will vary.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAS-10-274.html